Psychedelics: Stepping Into the Unknown

 As the head of Australia’s first clinical psychedelic laboratory, Dr Paul Liknaitzky is fast emerging as a leader in this ground-breaking area of research. In a world first, Dr Liknaitzky and his team at Monash University trial the use of psilocybin (the active ingredient found in ‘magic mushrooms’) in psychedelic assisted therapy to treat Generalised Anxiety Disorder (GAD). For two years, Psychedelics: Stepping into the Unknown is granted exclusive access to what unfolds.

We meet the participants before their treatment begins and witness their daily struggles living with anxiety. We follow them through treatment, including extraordinary psychedelic dosing sessions, and intense and intimate therapy. Their experiences are raw, courageous, and life changing.

After two eventful years, the trial concludes, and the brave participants reflect on the impact it has had on their lives. For Dr Liknaitzky, the Monash team and the many Australians seeking relief from their mental health struggles, the future of psychedelic therapy is only just beginning. 

The film will be followed by a discussion with SA TAIP’s Head of Policy and Strategy and neuroscientist Dr Cristina Kroon, and child and adolescent psychiatrist Dr Triin Arbo.

18:00–18:05 Introduction
18:05–19:20 Film
19:25–20:10 Discussion and Q&A (Dr Cristina Kroon and Dr Triin Arbo)